NCT03391414View on ClinicalTrials.gov

Effects of Inhaled Bicarbonate on Airway pH in Cystic Fibrosis

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

August 31, 2014

Primary Completion Date

July 31, 2016

Study Completion Date

July 31, 2016

Conditions
Cystic Fibrosis
Interventions
DRUG

hypertonic bicarbonate

8.4% sodium bicarbonate inhaled

DRUG

sodium chloride

7% sodium chloride inhaled

Trial Locations (2)

15213

UPMC Fallk Clinic, Pittsburgh

15224

Children's Hospital of Pittsburgh of UPMC, Pittsburgh

All Listed Sponsors
collaborator

Cystic Fibrosis Foundation

OTHER

lead

Joseph Pilewski

OTHER

NCT03391414 - Effects of Inhaled Bicarbonate on Airway pH in Cystic Fibrosis | Biotech Hunter | Biotech Hunter